Concepts (193)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Brain Neoplasms | 5 | 2018 | 587 | 0.670 |
Why?
|
| Glioma | 3 | 2018 | 133 | 0.630 |
Why?
|
| Neoplasm Recurrence, Local | 5 | 2017 | 337 | 0.390 |
Why?
|
| Skin Neoplasms | 2 | 2004 | 206 | 0.390 |
Why?
|
| Mixed Tumor, Mesodermal | 1 | 2010 | 2 | 0.380 |
Why?
|
| Neuroectodermal Tumors | 1 | 2010 | 2 | 0.380 |
Why?
|
| Microvessels | 1 | 2009 | 23 | 0.360 |
Why?
|
| Temporal Lobe | 1 | 2009 | 41 | 0.350 |
Why?
|
| Ovarian Neoplasms | 1 | 2010 | 87 | 0.350 |
Why?
|
| Immunohistochemistry | 6 | 2010 | 519 | 0.340 |
Why?
|
| Astrocytoma | 2 | 2010 | 30 | 0.340 |
Why?
|
| Genes, erbB-1 | 1 | 2008 | 15 | 0.320 |
Why?
|
| PTEN Phosphohydrolase | 1 | 2008 | 20 | 0.320 |
Why?
|
| Chromosome Aberrations | 1 | 2008 | 21 | 0.320 |
Why?
|
| Hippocampus | 1 | 2009 | 185 | 0.320 |
Why?
|
| Brain | 2 | 2005 | 930 | 0.310 |
Why?
|
| Brain Chemistry | 1 | 2005 | 30 | 0.260 |
Why?
|
| Neurons | 2 | 2009 | 394 | 0.260 |
Why?
|
| Meningeal Neoplasms | 2 | 2017 | 46 | 0.250 |
Why?
|
| Carcinoma, Squamous Cell | 2 | 2018 | 142 | 0.250 |
Why?
|
| Meningioma | 2 | 2017 | 51 | 0.250 |
Why?
|
| Antigens, Differentiation, B-Lymphocyte | 1 | 2004 | 5 | 0.250 |
Why?
|
| Lectins | 1 | 2004 | 10 | 0.250 |
Why?
|
| Humans | 25 | 2018 | 29093 | 0.250 |
Why?
|
| Middle Aged | 13 | 2018 | 10829 | 0.250 |
Why?
|
| Cell Communication | 1 | 2004 | 30 | 0.240 |
Why?
|
| Carcinoma, Merkel Cell | 1 | 2004 | 10 | 0.240 |
Why?
|
| Cell Adhesion Molecules | 1 | 2004 | 45 | 0.240 |
Why?
|
| Microglia | 1 | 2004 | 48 | 0.240 |
Why?
|
| Antigens, CD | 1 | 2004 | 100 | 0.240 |
Why?
|
| Cytokines | 1 | 2004 | 243 | 0.220 |
Why?
|
| Hyperplasia | 1 | 2002 | 38 | 0.220 |
Why?
|
| Glioblastoma | 2 | 2018 | 143 | 0.220 |
Why?
|
| Dementia | 1 | 2005 | 234 | 0.220 |
Why?
|
| Alzheimer Disease | 1 | 2005 | 312 | 0.210 |
Why?
|
| Female | 16 | 2018 | 18164 | 0.210 |
Why?
|
| Melanoma | 1 | 2002 | 148 | 0.200 |
Why?
|
| Cell Transformation, Neoplastic | 2 | 2013 | 57 | 0.190 |
Why?
|
| Aged | 10 | 2018 | 9487 | 0.180 |
Why?
|
| Vasculitis, Central Nervous System | 1 | 2018 | 5 | 0.160 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2018 | 39 | 0.160 |
Why?
|
| Genomics | 1 | 2018 | 82 | 0.160 |
Why?
|
| Tumor Burden | 1 | 2017 | 60 | 0.150 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2017 | 68 | 0.150 |
Why?
|
| Eye Evisceration | 1 | 2017 | 1 | 0.150 |
Why?
|
| Acrylic Resins | 1 | 2017 | 2 | 0.150 |
Why?
|
| Orbital Implants | 1 | 2017 | 2 | 0.150 |
Why?
|
| Survival Rate | 3 | 2018 | 795 | 0.150 |
Why?
|
| Prosthesis Implantation | 1 | 2017 | 35 | 0.150 |
Why?
|
| Adult | 8 | 2017 | 8420 | 0.150 |
Why?
|
| Orbit | 1 | 2017 | 17 | 0.150 |
Why?
|
| Genome, Human | 1 | 2017 | 129 | 0.150 |
Why?
|
| Neoplasm Proteins | 1 | 2017 | 141 | 0.140 |
Why?
|
| Hydrogels | 1 | 2017 | 103 | 0.140 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2018 | 1218 | 0.140 |
Why?
|
| Biocompatible Materials | 1 | 2017 | 210 | 0.140 |
Why?
|
| Male | 12 | 2018 | 17807 | 0.130 |
Why?
|
| Ganglioglioma | 1 | 2015 | 6 | 0.130 |
Why?
|
| Models, Biological | 2 | 2008 | 373 | 0.120 |
Why?
|
| Epidermal Cyst | 1 | 2013 | 4 | 0.120 |
Why?
|
| Aged, 80 and over | 4 | 2012 | 3717 | 0.120 |
Why?
|
| Cyclin D1 | 1 | 2013 | 15 | 0.120 |
Why?
|
| Spinal Cord Neoplasms | 1 | 2013 | 10 | 0.120 |
Why?
|
| Mammary Neoplasms, Experimental | 1 | 2013 | 25 | 0.120 |
Why?
|
| Lung Neoplasms | 2 | 2008 | 384 | 0.110 |
Why?
|
| Transcription Factors | 1 | 2013 | 172 | 0.110 |
Why?
|
| Nitrogen Mustard Compounds | 1 | 2012 | 4 | 0.110 |
Why?
|
| Lymphoma, Non-Hodgkin | 1 | 2012 | 20 | 0.100 |
Why?
|
| Antineoplastic Agents, Alkylating | 1 | 2012 | 40 | 0.100 |
Why?
|
| Disease Progression | 2 | 2018 | 572 | 0.100 |
Why?
|
| Central Nervous System Neoplasms | 1 | 2012 | 28 | 0.100 |
Why?
|
| Diagnosis, Differential | 2 | 2010 | 493 | 0.100 |
Why?
|
| Breast Neoplasms | 2 | 2018 | 666 | 0.100 |
Why?
|
| Prognosis | 3 | 2018 | 1362 | 0.100 |
Why?
|
| Medulloblastoma | 1 | 2010 | 7 | 0.100 |
Why?
|
| Cerebellar Neoplasms | 1 | 2010 | 11 | 0.100 |
Why?
|
| Ploidies | 1 | 2010 | 7 | 0.090 |
Why?
|
| Ependymoma | 1 | 2010 | 5 | 0.090 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2010 | 33 | 0.090 |
Why?
|
| Radiotherapy | 1 | 2010 | 74 | 0.090 |
Why?
|
| Frontal Lobe | 1 | 2010 | 45 | 0.090 |
Why?
|
| DNA, Neoplasm | 1 | 2010 | 58 | 0.090 |
Why?
|
| Esophagitis | 1 | 2009 | 5 | 0.090 |
Why?
|
| CA2 Region, Hippocampal | 1 | 2009 | 1 | 0.090 |
Why?
|
| Collagen Type IV | 1 | 2009 | 8 | 0.090 |
Why?
|
| Sclerosis | 1 | 2009 | 10 | 0.090 |
Why?
|
| Radial Neuropathy | 1 | 2009 | 11 | 0.090 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2009 | 16 | 0.090 |
Why?
|
| Eosinophilia | 1 | 2009 | 16 | 0.090 |
Why?
|
| Radial Nerve | 1 | 2009 | 17 | 0.090 |
Why?
|
| Alkaline Phosphatase | 1 | 2009 | 36 | 0.090 |
Why?
|
| Crohn Disease | 1 | 2009 | 25 | 0.090 |
Why?
|
| Migraine Disorders | 1 | 2010 | 58 | 0.090 |
Why?
|
| Cell Death | 1 | 2009 | 71 | 0.090 |
Why?
|
| Nerve Sheath Neoplasms | 1 | 2009 | 6 | 0.090 |
Why?
|
| Intestines | 1 | 2009 | 54 | 0.090 |
Why?
|
| Image Enhancement | 1 | 2009 | 70 | 0.090 |
Why?
|
| Neural Conduction | 1 | 2009 | 81 | 0.090 |
Why?
|
| Spinal Nerves | 1 | 2009 | 65 | 0.080 |
Why?
|
| Radiosurgery | 1 | 2012 | 322 | 0.080 |
Why?
|
| Hemangioma, Capillary | 1 | 2008 | 3 | 0.080 |
Why?
|
| Respiratory Distress Syndrome, Newborn | 1 | 2008 | 8 | 0.080 |
Why?
|
| Aneuploidy | 1 | 2008 | 8 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 10 | 1 | 2008 | 8 | 0.080 |
Why?
|
| Monosomy | 1 | 2008 | 5 | 0.080 |
Why?
|
| Chromosomes, Human, Pair 7 | 1 | 2008 | 15 | 0.080 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2008 | 37 | 0.080 |
Why?
|
| Cell Differentiation | 1 | 2010 | 436 | 0.080 |
Why?
|
| Chromosome Mapping | 1 | 2008 | 190 | 0.080 |
Why?
|
| Supranuclear Palsy, Progressive | 1 | 2005 | 2 | 0.070 |
Why?
|
| Neurofibrillary Tangles | 1 | 2005 | 7 | 0.070 |
Why?
|
| Animals | 4 | 2017 | 7297 | 0.070 |
Why?
|
| tau Proteins | 1 | 2005 | 38 | 0.070 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 2005 | 20 | 0.060 |
Why?
|
| Apolipoproteins E | 1 | 2005 | 97 | 0.060 |
Why?
|
| Base Sequence | 1 | 2005 | 240 | 0.060 |
Why?
|
| Age Factors | 1 | 2008 | 1108 | 0.060 |
Why?
|
| Disease-Free Survival | 2 | 2017 | 281 | 0.060 |
Why?
|
| Child | 3 | 2017 | 2219 | 0.060 |
Why?
|
| Feedback, Physiological | 1 | 2004 | 10 | 0.060 |
Why?
|
| Blotting, Western | 1 | 2005 | 281 | 0.060 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2004 | 2 | 0.060 |
Why?
|
| Keratin-20 | 1 | 2004 | 6 | 0.060 |
Why?
|
| Intermediate Filament Proteins | 1 | 2004 | 9 | 0.060 |
Why?
|
| Lymphocytes, Tumor-Infiltrating | 1 | 2004 | 9 | 0.060 |
Why?
|
| Culture Media, Conditioned | 1 | 2004 | 52 | 0.060 |
Why?
|
| Calcium Channel Blockers | 1 | 2004 | 49 | 0.060 |
Why?
|
| Ligands | 1 | 2004 | 81 | 0.060 |
Why?
|
| Coculture Techniques | 1 | 2004 | 74 | 0.060 |
Why?
|
| Analysis of Variance | 1 | 2005 | 454 | 0.060 |
Why?
|
| Presynaptic Terminals | 1 | 2004 | 36 | 0.060 |
Why?
|
| Lipopolysaccharides | 1 | 2004 | 107 | 0.060 |
Why?
|
| Mice | 2 | 2013 | 2368 | 0.060 |
Why?
|
| Lymphatic Metastasis | 1 | 2004 | 156 | 0.060 |
Why?
|
| Regression Analysis | 1 | 2004 | 274 | 0.060 |
Why?
|
| Genotype | 1 | 2005 | 735 | 0.060 |
Why?
|
| Mutation | 2 | 2017 | 466 | 0.060 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2004 | 200 | 0.060 |
Why?
|
| Aging | 1 | 2009 | 881 | 0.060 |
Why?
|
| Adolescent | 2 | 2017 | 3254 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2004 | 641 | 0.050 |
Why?
|
| RNA, Messenger | 1 | 2004 | 514 | 0.050 |
Why?
|
| Cells, Cultured | 1 | 2004 | 799 | 0.050 |
Why?
|
| Macrophages | 1 | 2002 | 188 | 0.050 |
Why?
|
| Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2018 | 12 | 0.040 |
Why?
|
| Sulfones | 1 | 2018 | 14 | 0.040 |
Why?
|
| Indans | 1 | 2018 | 25 | 0.040 |
Why?
|
| RNA Interference | 1 | 2018 | 76 | 0.040 |
Why?
|
| RNA, Small Interfering | 1 | 2018 | 109 | 0.040 |
Why?
|
| Electroencephalography | 1 | 2018 | 71 | 0.040 |
Why?
|
| DNA Repair | 1 | 2017 | 50 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2017 | 3111 | 0.040 |
Why?
|
| Injections | 1 | 2017 | 61 | 0.040 |
Why?
|
| Rabbits | 1 | 2017 | 185 | 0.040 |
Why?
|
| Salvage Therapy | 1 | 2015 | 118 | 0.030 |
Why?
|
| Tomography, X-Ray Computed | 2 | 2010 | 871 | 0.030 |
Why?
|
| Infant | 1 | 2017 | 969 | 0.030 |
Why?
|
| Mammary Tumor Virus, Mouse | 1 | 2013 | 3 | 0.030 |
Why?
|
| G2 Phase | 1 | 2013 | 14 | 0.030 |
Why?
|
| Child, Preschool | 1 | 2017 | 1167 | 0.030 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 436 | 0.030 |
Why?
|
| Mitosis | 1 | 2013 | 22 | 0.030 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2013 | 20 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 525 | 0.030 |
Why?
|
| Thoracic Vertebrae | 1 | 2013 | 42 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2013 | 3099 | 0.030 |
Why?
|
| Disease Models, Animal | 1 | 2017 | 980 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2013 | 103 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 249 | 0.030 |
Why?
|
| Promoter Regions, Genetic | 1 | 2013 | 212 | 0.030 |
Why?
|
| Neoplasm Metastasis | 1 | 2013 | 199 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2013 | 249 | 0.030 |
Why?
|
| Radiometry | 1 | 2012 | 39 | 0.030 |
Why?
|
| Treatment Failure | 1 | 2012 | 159 | 0.030 |
Why?
|
| Apoptosis | 1 | 2013 | 337 | 0.030 |
Why?
|
| Craniopharyngioma | 1 | 2010 | 8 | 0.020 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2010 | 37 | 0.020 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2010 | 33 | 0.020 |
Why?
|
| Pituitary Neoplasms | 1 | 2010 | 17 | 0.020 |
Why?
|
| Proton Pump Inhibitors | 1 | 2009 | 11 | 0.020 |
Why?
|
| Vasculitis | 1 | 2009 | 23 | 0.020 |
Why?
|
| Glomerulonephritis | 1 | 2009 | 21 | 0.020 |
Why?
|
| Deglutition Disorders | 1 | 2009 | 50 | 0.020 |
Why?
|
| Sarcoidosis | 1 | 2009 | 27 | 0.020 |
Why?
|
| Pneumonectomy | 1 | 2008 | 6 | 0.020 |
Why?
|
| Rare Diseases | 1 | 2008 | 20 | 0.020 |
Why?
|
| Thoracotomy | 1 | 2008 | 22 | 0.020 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 89 | 0.020 |
Why?
|
| Ultrasonography | 1 | 2009 | 345 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2008 | 598 | 0.020 |
Why?
|
| Severity of Illness Index | 1 | 2008 | 863 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 2108 | 0.010 |
Why?
|
| Risk Assessment | 1 | 2008 | 1305 | 0.010 |
Why?
|